Results 31 to 40 of about 41,662 (214)

Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism [PDF]

, 2017
BACKGROUND: Long‐term medical management of hypersomatotropism (HS) in cats has proved unrewarding. Pasireotide, a novel somatostatin analogue, decreases serum insulin‐like growth factor 1 (IGF‐1) and improves insulin sensitivity in cats with HS when ...
Abraham, Berg, Bruns, Church, Colao, Colao, Combes, Cozzi, Dowling, Dunning, Feelders, Freda, Gadelha, Henry, Hofland, Hubina, Hussaini, Jaffe, Katznelson, Kurosaki, Lamb, Laron, Ma, Meij, Meij, Myers, Niessen, Niessen, Niessen, Patel, Petersenn, Peterson, Reubi, Reusch, Reusch, Sathyapalan, Schaefer, Scudder, Shanik, Slingerland, Slingerland, Theodoropoulou, Tyson, Zambre   +43 more
core   +2 more sources

Serum Levels of Asprosin, a Novel Adipokine, Are Significantly Lowered in Patients with Acromegaly

International Journal of Endocrinology, 2020
Background. Asprosin is a novel identified adipokine secreted mainly by white adipose tissue, which is elevated in metabolic diseases such as diabetes and obesity.
Xiaoan Ke, Lian Duan, Fengying Gong, Yuelun Zhang, Kan Deng, Yong Yao, Linjie Wang, Hui Pan, Huijuan Zhu   +8 more
doaj   +1 more source

Adiponectin and Cardiac Hypertrophy in Acromegaly [PDF]

, 2016
Background. Adiponectin is an adipocytes-derived hormone which has been shown to possess insulin-sensitizing, antiatherogenic, and anti-inflammatory properties. In acromegaly, the data on adiponectin is contradictory. The relationship between adiponectin
Akdag, B, Akin, F, Gurbulak, S, Kaptanoglu, B, Tanriverdi, H, Topsakal, S, Yaylali, GF, Yerlikaya, E   +7 more
core   +2 more sources

Insulin Resistance in Patients With Acromegaly

Frontiers in Endocrinology, 2019
Acromegaly is characterized by chronic overproduction of growth hormone (GH) that leads to insulin resistance, glucose intolerance and, ultimately, diabetes. The GH-induced sustained stimulation of lipolysis plays a major role not only in the development
Greisa Vila, Jens Otto L. Jørgensen, Anton Luger, Günter K. Stalla   +3 more
doaj   +1 more source

Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects. [PDF]

, 2011
Objective  (i) To analyse the predictors of GH suppression after standard glucose load (oGTT) in the healthy population and (ii) to establish the 97th percentile of GH nadir post-oGTT according to these variables.
AURIEMMA, RENATA SIMONA, COLAO, ANNAMARIA, GALDIERO, MARIANO, GRASSO, LUDOVICA FRANCESCA STELLA, LOMBARDI, GAETANO, PIVONELLO, CLAUDIA, PIVONELLO, ROSARIO, SAVASTANO, SILVIA   +7 more
core   +1 more source

Clinical characteristics and efficacy of acromegaly treatment in the Udmurt Republic

Alʹmanah Kliničeskoj Mediciny, 2022
Background: Acromegaly is a severe neuroendocrine disorder caused by chronic overproduction of growth hormone and insulin-like growth factor 1 and associated with a variety of clinical manifestations, debilitating complications and progressive disability,
Guzel M. Nurullina, Guzyal I. Akhmadullina, Irina S. Maslova, Alexandra R. Nikolaeva   +3 more
doaj   +1 more source

Acromegaly with metastatic renal cell carcinoma: Lung, gluteal and scapular metastasis

Medicine Science, 2018
The association between acromegaly and increased incidence of malignancy has been reported due to high GH and IGF levels. Although the incidence of all malignancies increases in patients with acromegaly, renal cell carcinoma (RCC) has been rarely ...
Ziynet Alphan Uc, Ozgur Demir, Suheyla Gorar, Sevim Gullu   +3 more
doaj   +1 more source

Evaluation and Diagnostic Potential of Serum Ghrelin in Feline Hypersomatotropism and Diabetes Mellitus [PDF]

, 2015
BACKGROUND: Ghrelin is a growth hormone secretagogue. It is a potent regulator of energy homeostasis. Ghrelin concentration is down‐regulated in humans with hypersomatotropism (HS) and increases after successful treatment. Additionally, ghrelin secretion
Appleton, Barkan, Bedendi, Belsito, Berg, Bhatti, Brearley, Briatore, Cappiello, Cummings, Dezaki, Dunning, Erdmann, Feldman, Freda, Gelling, Ida, Jenkins, Jensen, Kawamata, Kojima, Kojima, Kozakowski, Krzyzanowska-Świniarska, Martin, McLaughlin, Meij, Natalucci, Niessen, Niessen, Niessen, Niessen, Peino, Pöykkö, Reusch, Roemmler, Saad, Sofer, Soriano-Guillén, Takaya, Tschuor, Ueno, Yada   +42 more
core   +1 more source

Pasireotide for the Medical Management of Feline Hypersomatotropism [PDF]

, 2015
BACKGROUND: Feline hypersomatotropism (HST) is a cause of diabetes mellitus in cats. Pasireotide is a novel multireceptor ligand somatostatin analog that improves biochemical control of humans with HST.
Abraham, Adams, Alt, Appleton, Bhayana, Bruns, Castillo, Church, Colao, Colao, Cuevas-Ramos, Fedele, Fernandez-Rodriguez, Fougner, Golor, Henry, Hofland, Juul, Katznelson, Kvols, Lamb, Lamberts, Maxwell, Meij, Miller, Murray, Myers, Niessen, Niessen, Niessen, Niessen, Petrus, Polska, Rand, Ray, Schmid, Schmid, Sheppard, Slingerland, Sohmiya, Starkey, Stolk, Taboada, Wajchenberg, Zatelli, Zou   +45 more
core   +1 more source

Guidelines on diagnostics and treatment of acromegaly (draft)

Ожирение и метаболизм
We recommend acromegaly to be ruled in all patients with characteristic changes in appearance (A3). In all patients without characteristic changes in appearance, we recommend to rule out acromegaly, if several clinical signs suspicious for acromegaly are
E. G. Przhiyalkovskaya, N. G. Mokrysheva, E. A. Troshina, G. A. Melnichenko, I. I. Dedov, M. B. Antsiferov, L. I. Astafieva, T. P. Bardymova, Zh. E. Belaya, G. R. Vagapova, S. Yu. Vorotnikova, A. Yu. Grigoriev, E. N. Grineva, L. K. Dzeranova, I. A. Ilovaiskaya, P. L. Kalinin, A. M. Lapshina, A. S. Lutsenko, E. O. Mamedova, E. I. Marova, M. A. Perepelova, E. A. Pigarova, V. S. Pronin, L. Ya. Rozhinskaya, Yu. Yu. Trunin, A. S. Shutova   +25 more
doaj   +1 more source